Literature DB >> 25939970

Laser arytenoidectomy and posterior cordotomy in a patient with bilateral vocal cord paralysis due to multiple system atrophy.

Ayesha Mahmud1, Lucy H A Strens2, Miroslav Tedla3.   

Abstract

Bilateral vocal cord paralysis leading to stridor is a known but rare complication of Parkinson's disease (PD) and a recognised complication of multiple system atrophy (MSA). Tracheostomy is a commonly offered treatment, leading to substantial adaptations and lifestyle changes for the patient. Patients can struggle to manage a tracheostomy due to the tremor and bradykinesia associated with their parkinsonism. We report a case of bilateral vocal cord paralysis leading to significant stridor in a patient with atypical parkinsonism (probable MSA). To avoid tracheostomy, our patient underwent successful right-sided laser arytenoidectomy and posterior cordotomy as a day-case procedure. At follow-up, he had a weaker voice but complete recovery from the shortness of breath and stridor. He was very satisfied with the outcome. We conclude that, despite resulting in a weaker voice, this procedure offers an option to the patient that improves quality of life. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25939970      PMCID: PMC4434268          DOI: 10.1136/bcr-2014-206156

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Effects of tracheostomy on well-being and body-image perceptions.

Authors:  Dror Gilony; Dalia Gilboa; Tzvia Blumstein; Havi Murad; Yoav P Talmi; Jona Kronenberg; Michael Wolf
Journal:  Otolaryngol Head Neck Surg       Date:  2005-09       Impact factor: 3.497

2.  Tracheostomy can fatally exacerbate sleep-disordered breathing in multiple system atrophy.

Authors:  Michael H Silber
Journal:  Neurology       Date:  2008-03-18       Impact factor: 9.910

3.  Effect of laser arytenoidectomy on respiratory stridor caused by multiple system atrophy.

Authors:  Shun-ichi Chitose; Atsushi Kikuchi; Keiko Ikezono; Hirohito Umeno; Tadashi Nakashima
Journal:  J Clin Sleep Med       Date:  2012-12-15       Impact factor: 4.062

4.  Bilateral vocal fold paresis and multiple system atrophy.

Authors:  Joel H Blumin; Gerald S Berke
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-12

5.  Laser arytenoidectomy for bilateral vocal fold palsy in Parkinson's disease.

Authors:  A Qayyum; K Mierzwa; M See; A Sharma; P Q Montgommery
Journal:  J Laryngol Otol       Date:  2005-10       Impact factor: 1.469

6.  [Usefulness of laser arytenoidectomy and laterofixation in treatment of bilateral vocal cord paralysis].

Authors:  Maciej Misiołek; Leszek Kłębukowski; Grażyna Lisowska; Eugeniusz Czecior; Wojciech Ścierski; Bogusława Orecka; Grzegorz Namysłowski
Journal:  Otolaryngol Pol       Date:  2012 Mar-Apr

7.  Tracheostomy abolishes paradoxical activation of the vocal cord adductor in multiple system atrophy.

Authors:  Keisuke Shiba; Shiroh Isono
Journal:  Auris Nasus Larynx       Date:  2006-01-06       Impact factor: 1.863

8.  Management of impaired vocal fold movement during sleep in a patient with Shy-Drager syndrome.

Authors:  H Umeno; Y Ueda; K Mori; K Chijiwa; T Nakashima; N M Kotby
Journal:  Am J Otolaryngol       Date:  2000 Sep-Oct       Impact factor: 1.808

9.  Tracheostomy can fatally exacerbate sleep-disordered breathing in multiple system atrophy.

Authors:  K Jin; S Okabe; K Chida; N Abe; T Kimpara; A Ohnuma; H Nomura; Y Itoyama; H Onodera
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

  9 in total
  2 in total

1.  Multiple system atrophy laryngeal stridor treated with radiofrequency-assisted posterior cordotomy and arytenoidectomy.

Authors:  Sergio A Castillo-Torres; María Viti; Viviana Alexandra Martínez-Villota; Malco Rossi; Marcelo Merello
Journal:  Clin Auton Res       Date:  2022-07-19       Impact factor: 5.625

2.  Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?

Authors:  Florin Gandor; Annemarie Vogel; Inga Claus; Sigrid Ahring; Doreen Gruber; Hans-Jochen Heinze; Rainer Dziewas; Georg Ebersbach; Tobias Warnecke
Journal:  Mov Disord       Date:  2020-08-05       Impact factor: 10.338

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.